Details
Stereochemistry | ACHIRAL |
Molecular Formula | C17H16N2O |
Molecular Weight | 264.3217 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC1=CC=CC=C1N2C(C)=NC3=CC=CC=C3C2=O
InChI
InChIKey=UVTJKLLUVOTSOB-UHFFFAOYSA-N
InChI=1S/C17H16N2O/c1-3-13-8-4-7-11-16(13)19-12(2)18-15-10-6-5-9-14(15)17(19)20/h4-11H,3H2,1-2H3
Etaqualone (Aolan, Athinazone) is an analog of the hypnotic methaqualone, a non-barbiturate sedative it was developed and marked in France. Etaqualone possesses sedative and hypnotic properties and was used to treat insomnia resulting from its agonist activity at the β subtype of the GABAa receptor.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: β subtype of the GABAa receptor Sources: http://www.gutenberg.us/articles/eng/Etaqualone |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
[EFFECTIVE SEDATION IN MEDICAL PRACTICE. EXPERIENCES WITH THE NEW DAYTIME SEDATIVE AOLAN]. | 1965 Mar 31 |
|
[On the polarography of 2-methyl-3-(2-methylphenyl)-3,4-dihydroquinazolinone-(4) methaqualone, Dormutil) and 2-methyl-3-(2-ethylphenyl-3,4-dihydroquinazolinone-(4) (ethinazone, Aolan). 5. Polarography of heterocyclic compounds]. | 1967 Nov |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/14345007
Unknown
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-Etaqualone
Created by
admin on Fri Dec 15 16:36:50 GMT 2023 , Edited by admin on Fri Dec 15 16:36:50 GMT 2023
|
||
|
NCI_THESAURUS |
C29756
Created by
admin on Fri Dec 15 16:36:50 GMT 2023 , Edited by admin on Fri Dec 15 16:36:50 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
2256
Created by
admin on Fri Dec 15 16:36:50 GMT 2023 , Edited by admin on Fri Dec 15 16:36:50 GMT 2023
|
PRIMARY | |||
|
HFS3HB32J7
Created by
admin on Fri Dec 15 16:36:50 GMT 2023 , Edited by admin on Fri Dec 15 16:36:50 GMT 2023
|
PRIMARY | |||
|
CHEMBL2104633
Created by
admin on Fri Dec 15 16:36:50 GMT 2023 , Edited by admin on Fri Dec 15 16:36:50 GMT 2023
|
PRIMARY | |||
|
100000082370
Created by
admin on Fri Dec 15 16:36:50 GMT 2023 , Edited by admin on Fri Dec 15 16:36:50 GMT 2023
|
PRIMARY | |||
|
7432-25-9
Created by
admin on Fri Dec 15 16:36:50 GMT 2023 , Edited by admin on Fri Dec 15 16:36:50 GMT 2023
|
PRIMARY | |||
|
SUB07263MIG
Created by
admin on Fri Dec 15 16:36:50 GMT 2023 , Edited by admin on Fri Dec 15 16:36:50 GMT 2023
|
PRIMARY | |||
|
m5039
Created by
admin on Fri Dec 15 16:36:50 GMT 2023 , Edited by admin on Fri Dec 15 16:36:50 GMT 2023
|
PRIMARY | Merck Index | ||
|
23914
Created by
admin on Fri Dec 15 16:36:50 GMT 2023 , Edited by admin on Fri Dec 15 16:36:50 GMT 2023
|
PRIMARY | |||
|
96163
Created by
admin on Fri Dec 15 16:36:50 GMT 2023 , Edited by admin on Fri Dec 15 16:36:50 GMT 2023
|
PRIMARY | |||
|
C65554
Created by
admin on Fri Dec 15 16:36:50 GMT 2023 , Edited by admin on Fri Dec 15 16:36:50 GMT 2023
|
PRIMARY | |||
|
DTXSID60225333
Created by
admin on Fri Dec 15 16:36:50 GMT 2023 , Edited by admin on Fri Dec 15 16:36:50 GMT 2023
|
PRIMARY | |||
|
Etaqualone
Created by
admin on Fri Dec 15 16:36:50 GMT 2023 , Edited by admin on Fri Dec 15 16:36:50 GMT 2023
|
PRIMARY | |||
|
3192
Created by
admin on Fri Dec 15 16:36:50 GMT 2023 , Edited by admin on Fri Dec 15 16:36:50 GMT 2023
|
PRIMARY |
ACTIVE MOIETY